Pulmonary toxicity of inhaled aerosolized prostacyclin therapy - An observational study

被引：21

作者：

van Heerden, PV

Caterina, P

Filion, P

Spagnolo, DV

Gibbs, NM

机构：

[1] Sir Charles Gairdiner Hosp, Dept Intens Care, PathCtr, QEII Med Ctr, Perth, WA, Australia

[2] Sir Charles Gairdiner Hosp, Dept Histopathol & Anaesthesia, PathCtr, QEII Med Ctr, Perth, WA, Australia

[3] Univ Western Australia, Dept Pharmacol, Perth, WA 6009, Australia

来源：

ANAESTHESIA AND INTENSIVE CARE | 2000年 / 28卷 / 02期

关键词：

prostaglandin : prostacyclin; inhalational; toxicity; pulmonary; prostacyclin;

D O I：

10.1177/0310057X0002800206

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

Large white/landrace piglets (mass 11 to 21 kg) were exposed to aerosolized alkaline glycine diluent (n=2) or inhaled aerosolized prostacyclin (n=2) for five to eight hours. Pigs receiving these aerosols developed mild acute sterile tracheitis, involving the superficial layers of the trachea shown histologically and ultrastructurally. Pigs receiving the diluent aerosol also showed mild inflammatory changes in the bronchioles, These findings suggest caution with the use of high volumes of aerosolized alkaline glycine diluent during inhaled aerosolized prostacyclin therapy.

引用

收藏

页码：161 / 166

页数：6

相关论文

共 40 条

[11] Eight hours' inhalation of prostacyclin (PGI(2)) in healthy lambs: Effects on tracheal, bronchial, and alveolar morphology [J].

Habler, O ;

Kleen, M ;

Takenaka, S ;

Leiderer, R ;

Pusch, R ;

Welte, M ;

Zwissler, B ;

Messmer, K .

INTENSIVE CARE MEDICINE, 1996, 22 (11) :1232-1238

[12] Inhalation of prostacyclin (PGI(2)) for 8 hours does not produce signs of acute pulmonary toxicity in healthy lambs [J].

Habler, O ;

Kleen, M ;

Zwissler, B ;

Pusch, R ;

Welte, M ;

Vogelmeier, C ;

Kempter, B ;

Krombach, F ;

Messmer, K .

INTENSIVE CARE MEDICINE, 1996, 22 (05) :426-433

[13] Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance [J].

Haraldsson, Å ;

Kieler-Jensen, N ;

Nathorst-Westfelt, U ;

Bergh, CH ;

Ricksten, SE .

CHEST, 1998, 114 (03) :780-786

[14] Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: A pharmacodynamic study [J].

Haraldsson, A ;

KielerJensen, N ;

Ricksten, SE .

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 1996, 10 (07) :864-868

[15] Effects of prostacyclin on myocardial hemodynamics and metabolism after coronary artery bypass grafting [J].

KielerJensen, N ;

Milocco, I ;

Kirno, K ;

Houltz, E ;

Ricksten, SE .

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 1996, 10 (06) :741-747

[16] Use of nebulised prostacyclin to ascertain reversibility of secondary pulmonary hypertension [J].

McGinn, PV ;

Black, AJR .

AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1996, 26 (02) :234-235

[17]

Mikhail G, 1997, EUR HEART J, V18, P1499

[18] PROSTACYCLIN AND BLOOD-COAGULATION [J].

MONCADA, S ;

VANE, JR .

DRUGS, 1981, 21 (06) :430-437

[19] Aerosolized prostacyclin and iloprost in severe pulmonary hypertension [J].

Olschewski, H ;

Walmrath, D ;

Schermuly, R ;

Ghofrani, A ;

Grimminger, F ;

Seeger, W .

ANNALS OF INTERNAL MEDICINE, 1996, 124 (09) :820-824

[20] AEROSOLIZED PROSTACYCLIN VERSUS INHALED NITRIC-OXIDE IN CHILDREN WITH SEVERE ACUTE RESPIRATORY-DISTRESS SYNDROME [J].

PAPPERT, D ;

BUSCH, T ;

GERLACH, H ;

LEWANDOWSKI, K ;

RADERMACHER, P ;

ROSSAINT, R .

ANESTHESIOLOGY, 1995, 82 (06) :1507-1511

← 1 2 3 4 →